PMDA drug package insert
ペントシリン注射用1g
PMDA Prescription drug · 富士フイルム富山化学株式会社 · package insert Oct 25, 2021
Key facts
| Brand names | ペントシリン注射用1g, ペントシリン注射用2g |
|---|---|
| Nonproprietary names | ピペラシリンナトリウム |
| Companies | 製造販売元／富士フイルム富山化学株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 合成ペニシリン製剤 |
| Therapeutic category codes | 876131 |
| YJ codes | 6131403D1047, 6131403D2043 |
| Approval numbers | 15400EMZ00940000, 15400EMZ00941000 |
| Package insert edition | 第1版 |
| Package insert date | Oct 25, 2021 |
| PMDA document key | 400022_6131403D1047_3 |
| PMDA company code | 400022 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: